ArticleCancer chemotherapy and pharmacology2022

Elimination of tucatinib, a small molecule kinase inhibitor of HER2, is primarily governed by CYP2C8 enantioselective oxidation of gem-dimethyl.

Hao Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.